Healrna announced that it has received $29 million in a pre series A round of funding led by new investor, Ming Bioventures on March 10, 2023. The transaction also included participation from China-Singapore Suzhou Industrial Park Development Group Co., Ltd., Sequoia China Investment Management LLP, Shunwei, Inc., AAMA Angel Fund I, a fund managed by Asia America MultiTechnology Association, Investment Arm.